Previous close | 6.10 |
Open | 7.20 |
Bid | 6.00 |
Ask | 9.85 |
Strike | 34.00 |
Expiry date | 2024-06-21 |
Day's range | 7.20 - 7.20 |
Contract range | N/A |
Volume | |
Open interest | 24 |
PRINCETON, N.J., June 21, 2024--Bristol Myers Squibb Announces U.S. FDA Accelerated Approval of KRAZATI® (adagrasib) in Combination with Cetuximab for Adult Patients with...
PRINCETON, N.J., June 21, 2024--European Medicines Agency Validates Bristol Myers Squibb's Application for Subcutaneous Nivolumab
PRINCETON, N.J., June 20, 2024--Bristol Myers Squibb to Report Results for Second Quarter 2024 on July 26, 2024